8th Nov 2018 12:28 pm |
RNS |
Sierra Oncology Q3 2018 Results |
26th Oct 2018 7:00 am |
RNS |
Completion of Placing |
1st Oct 2018 7:00 am |
RNS |
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018 |
27th Sep 2018 1:03 pm |
RNS |
Notice of Results |
26th Sep 2018 7:00 am |
RNS |
TYK2/JAK1 selected for certain cancers |
11th Sep 2018 7:00 am |
RNS |
Pre-Close Trading Statement |
10th Sep 2018 7:00 am |
RNS |
Selection of TYK2/JAK1 for autoimmune diseases |
9th Aug 2018 1:15 pm |
RNS |
Sareum notes Sierra Oncology Q2 2018 Results |
11th Jul 2018 9:38 am |
RNS |
Notification of PCA Shareholding |
15th Jun 2018 7:00 am |
RNS |
Advisers |
31st May 2018 7:00 am |
RNS |
Sareum regains rights to Aurora+FLT3 inhibitors |
10th May 2018 12:21 pm |
RNS |
SRA737 trial update in Sierra Oncology Q1 Results |
24th Apr 2018 7:00 am |
RNS |
Sareum to Present at BioTrinity 2018 in London |
17th Apr 2018 12:45 pm |
RNS |
AACR 2018 Update |
15th Mar 2018 7:00 am |
RNS |
Late-breaker abstract for SRA737 accepted for AACR |
13th Mar 2018 7:00 am |
RNS |
Interim Results |
27th Feb 2018 12:50 pm |
RNS |
Sierra Oncology expands SRA737 development program |
22nd Feb 2018 7:00 am |
RNS |
Preclinical synergy of sra737 and PARP inhibitor |
13th Feb 2018 7:00 am |
RNS |
Notice of Interim Results |
20th Dec 2017 11:00 am |
RNS |
Issue of Options |
19th Dec 2017 7:00 am |
RNS |
Patent Grants in Japan & China for TYK2 Inhibitors |
14th Dec 2017 11:01 am |
RNS |
Result of AGM |
14th Dec 2017 7:00 am |
RNS |
AGM Statement |
20th Nov 2017 7:00 am |
RNS |
Notice of AGM and Annual Report & Accounts |
14th Nov 2017 12:05 pm |
RNS |
Placing |
31st Oct 2017 7:00 am |
RNS |
Sierra Reports Preclinical Data for Chk1 Inhibitor |
19th Oct 2017 7:00 am |
RNS |
Final Results |
9th Oct 2017 12:00 pm |
RNS |
Sierra Oncology host KOL Meeting on 12 Oct in NY |
18th Sep 2017 12:00 pm |
RNS |
Sierra Oncology to host call on Chk1 inhibitor |
22nd Aug 2017 7:00 am |
RNS |
Pre-Close Trading Statement |
19th Jun 2017 7:00 am |
RNS |
Sareum to Present at the ICCS 2017 |
5th Jun 2017 12:13 pm |
RNS |
Chk1 Clinical Trials Update |
31st May 2017 7:00 am |
RNS |
Sierra Oncology Granted US and EU Patents |
25th May 2017 7:00 am |
RNS |
Sierra Oncology to Present at ASCO Annual Meeting |
9th May 2017 7:00 am |
RNS |
Sareum to Present at BioTrinity 2017 |
9th Mar 2017 7:00 am |
RNS |
Director Shareholding |
20th Feb 2017 7:00 am |
RNS |
Half-year Results |
9th Feb 2017 7:00 am |
RNS |
Notice of Interim Results |
9th Jan 2017 12:05 pm |
RNS |
Milestone Payment from Chk1 Licence Agreement |
22nd Dec 2016 9:47 am |
RNS |
Result of General Meeting |